Insight | D. Boral Capital

Featured Insights

March 27, 2025

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

March 26, 2025

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

March 4, 2025

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

February 28, 2025

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

February 21, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

December 13, 2024

D. Boral Capital Served as Exclusive Placement Agent to FAVO Capital, Inc. (OTC Pink: FAVO) in connection with its $2.0 Million Private Placement

December 12, 2024

D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

December 10, 2024

D. Boral Capital Acted as Exclusive Placement Agent to Baijiayun Group Ltd (Nasdaq: RTC) in connection with its up to $15 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

December 6, 2024

D. Boral Capital acted as Exclusive Placement Agent to SRM Entertainment, Inc. (Nasdaq: SRM) in connection with its $1.7 Million Registered Direct Offering

December 2, 2024

D. Boral Capital Acted as Joint Bookrunner to Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) in connection with its $8.2 Million Initial Public Offering

Left 1 … 3 4 5 6 7 … 9 Right

December 17, 2024

D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau

March 27, 2025

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

March 26, 2025

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

March 4, 2025

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

February 28, 2025

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

February 21, 2025

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

December 10, 2024

D. Boral Capital Acted as Exclusive Placement Agent to Baijiayun Group Ltd (Nasdaq: RTC) in connection with its up to $15 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

December 6, 2024

D. Boral Capital acted as Exclusive Placement Agent to SRM Entertainment, Inc. (Nasdaq: SRM) in connection with its $1.7 Million Registered Direct Offering

December 2, 2024

D. Boral Capital Acted as Joint Bookrunner to Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) in connection with its $8.2 Million Initial Public Offering

November 25, 2024

D. Boral Capital Acted as Exclusive Placement Agent to Armlogi Holding Corp. (Nasdaq: BTOC) in connection with its up to $21 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

November 20, 2024

D. Boral Capital Served as Capital Markets Advisor to Nova Vision Acquisition Corporation (NASDAQ: NOVV) in connection with its $64.0 Million Completed Business Combination with Real Messenger

Left 1 … 3 4 5 6 7 8 Right

Insights

Featured Insights

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

D. Boral Capital Served as Exclusive Placement Agent to FAVO Capital, Inc. (OTC Pink: FAVO) in connection with its $2.0 Million Private Placement

D. Boral Capital Served as Co-Manager to ImmunityBio, Inc. (Nasdaq: IBRX) in connection with its $100.0 Million Underwritten Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Baijiayun Group Ltd (Nasdaq: RTC) in connection with its up to $15 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

D. Boral Capital acted as Exclusive Placement Agent to SRM Entertainment, Inc. (Nasdaq: SRM) in connection with its $1.7 Million Registered Direct Offering

D. Boral Capital Acted as Joint Bookrunner to Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) in connection with its $8.2 Million Initial Public Offering

D. Boral Capital: Philanthropic Endeavors Continue with Donations to Keep a Child Alive and Project Rosseau

D. Boral Capital Acted as Sole Bookrunner to Epsium Enterprise Limited (Nasdaq: EPSM) in connection with its $5.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Inspire Veterinary Partners, Inc. (Nasdaq: IVP) in connection with its up to $6.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq: PSTV) in connection with its up to $15.0 Million Private Placement

D. Boral Capital Acted as Joint Bookrunner to LZ Technology Holdings Limited (Nasdaq: LZMH) in connection with its $7.2 Million Initial Public Offering

D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Baijiayun Group Ltd (Nasdaq: RTC) in connection with its up to $15 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

D. Boral Capital acted as Exclusive Placement Agent to SRM Entertainment, Inc. (Nasdaq: SRM) in connection with its $1.7 Million Registered Direct Offering

D. Boral Capital Acted as Joint Bookrunner to Wing Yip Food Holdings Group Limited (Nasdaq: WYHG) in connection with its $8.2 Million Initial Public Offering

D. Boral Capital Acted as Exclusive Placement Agent to Armlogi Holding Corp. (Nasdaq: BTOC) in connection with its up to $21 Million Convertible Promissory Notes and $50 Million Standby Equity Purchase Agreement

D. Boral Capital Served as Capital Markets Advisor to Nova Vision Acquisition Corporation (NASDAQ: NOVV) in connection with its $64.0 Million Completed Business Combination with Real Messenger

Recent Transactions

November 20, 2024

Nova Vision Acquisition Corp Merger with Real Messenger

$64,000,000

November 15, 2024

374Water Inc.

$12,229,370

November 14, 2024

Pineapple Financial, Inc.

$1,000,000

November 12, 2024

Nature’s Miracle Holding Inc.

$3,000,000

November 8, 2024

Aduro Clean Technologies Inc.

$4,000,000

October 15, 2024

MicroVision, Inc.

$75,000,000

Follow Us